Profil
Melissa Angelini currently works at Procaps Group SA, as Co-Chief Executive Officer & VP-Finance from 2025.
Ms. Angelini also formerly worked at Blau Farmacêutica SA, as Head-Investor Relations and Biotoscana Investments SA, as Manager-Investor Relations from 2017 to 2019.
Ms. Angelini received her undergraduate degree from Universidad de Palermo and Masters Business Admin degree from Insper Institute of Education & Research.
Postes actifs de Melissa Angelini
| Sociétés | Poste | Début |
|---|---|---|
| SOFGEN PHARMA S.A. | Directeur Général | 29/01/2025 |
Anciens postes connus de Melissa Angelini
| Sociétés | Poste | Fin |
|---|---|---|
| BLAU FARMACÊUTICA S.A. | Public Communications Contact | - |
| BIOTOSCANA INVESTMENTS S.A. | Investor Relations Contact | - |
Formation de Melissa Angelini
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Universidad de Palermo
Universidad de Palermo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Insper Institute of Education & Research
Insper Institute of Education & Research Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Blau Farmacêutica SA
Blau Farmacêutica SA Pharmaceuticals: MajorHealth Technology Manufactures and wholesales pharmaceutical products | Health Technology |
Biotoscana Investments SA
Biotoscana Investments SA Pharmaceuticals: MajorHealth Technology Operates as a holding company whose subsidiaries engages in development, manufacture and commercialization of pharmaceutical products | Health Technology |
Procaps Group SA
Procaps Group SA Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets over-the-counter and prescription drugs, nutritional supplements and high-potential clinical solutions | Health Technology |
















